Oral obesity medications in development are poised to offer several potential advantages over their injectable counterparts, especially when it comes to patient experience and ease of managing obesity long-term. Here’s how the oral pipeline stacks up:
- No needles: For many people, the prospect of self-injecting weekly or daily is daunting. Oral medications remove this psychological and practical barrier.
- Simplified dosing: Oral formulations can be taken at home, on the go, and often without the need for refrigeration or special preparation, making adherence easier especially for needle-averse populations.
- Easier manufacturing and distribution: Tablets and capsules are often more scalable and cheaper to produce than biologics, which can potentially reduce overall patient costs.
- Global access: Orals can be more easily transported and stored—especially important in regions with limited healthcare infrastructure.
- Long-term adherence: Patients may feel more comfortable staying on oral medications long-term, improving outcomes in what is typically a chronic condition requiring lifelong management.
- Reduced stigma: Tablets and capsules are common whereas injectables are more private and can carry a connotation of “serious illness.”
Our Contribution to Oral Dosage Form Development
Colorcon plays a vital role in the development of patient-friendly oral obesity formulations. Key offerings include:
- Core excipients, such as binders, diluents and lubricants, that offer ease of manufacture, improved disintegration and enhanced stability
- Film coatings, for dosage form protection and improved aesthetics to ensure swallowability, brand differentiation, and compliance
- AnyCoat Hypromellose Polymers (HPMC), for oral suspensions and controlled release technologies
- Controlled atmosphere packaging, including desiccants for moisture protection, as well as other sorbents for oxygen and odor control
Final Thoughts
If you are looking to develop oral dosage forms for obesity applications, Colorcon is committed to supporting pharmaceutical companies in their quest to develop patient-friendly options. In subsequent blogs, we will delve deeper into each of Colorcon’s offerings, exploring the specific benefits and providing detailed insights on how these solutions can be tailored to meet the needs of oral obesity treatment development.